1016TiP LEAP-012 trial in progress: Pembrolizumab plus lenvatinib and transarterial chemoembolization (TACE) in patients with intermediate-stage hepatocellular carcinoma (HCC) not amenable to curative treatment

Authors :: D. Madoff
Sadahisa Ogasawara
Leonid Dubrovsky
Zhenggang Ren
Masatoshi Kudo
Richard S. Finn
Kalgi Mody
J.J. Li
Abby B. Siegel
Arndt Vogel
Anthony B. El-Khoueiry
Josep M. Llovet
Source :: Annals of Oncology. 31:S702-S703
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Hematology
Pembrolizumab
medicine.disease
Intermediate stage
chemistry.chemical_compound
chemistry
Curative treatment
Internal medicine
Hepatocellular carcinoma
medicine
In patient
Lenvatinib
business

Full Text Access

Tools